----- Original Message -----

From: Claudia Megaro

To: Kleszynski, Aloysius

Cc: info@isds.org ; info@aae.org ; sportdds@uic.edu ; rwesley@siumed.edu ; anthony@spina.us ; drajs@msn.com ; DIF1313@aol.com ; drmousel@att.net ; branallo@CDS.org ; lwozzie@aol.com ; michael.durbin@aaomembers.org ; mtk-dgk@sbcglobal.net ; mmbhumenik@yahoo.com ; grzenterp ; lcleary@CDS.org ; lgirardi@CDS.org ; drholba@sbcglobal.net ; rsorpassa@comcast.net ; joeungerdds@comcast.net ; grzenterprises@comcast.net ; ttiersky@comcast.net ; mbkrisko@sbcglobal.net ; csnell1@mchsi.com ; melrozdental1@yahoo.com ; lows@ada.org ; normanc@ada.org ; vignae@ada.org ; steffelc@ada.org ; richk@ada.org ; solidayt@ada.org ; sullivant@ada.org ; tankersleyr@ada.org ; Daniel.Bluthardt@illinois.gov ; Michael.McRaith@illinois.gov ; Lisa.Madigan@illinois.gov ; Pat.Quinn@illinois.gov#

Sent: Friday, December 26, 2008 5:21 AM

Subject: Sargenti Table Clinics

 

 

Dear Dr. Kleszynski,

 

Thank you for your reply. As an ethical dentist as you describe yourself,  you surely are  aware that the protecting the patient's best interest is the paramount ethical obligation of all dentists. Furthermore, it is unethical to practice or promote negligent dental practice. For more than a decade the American Association of Endodontists position paper is that the use of Sargenti  paste constitutes substandard practice. Endodontists set the standard of care in endodontic practice. Furthermore, all U.S. endodontic departments teach that Sargenti paste should not be used since it is a toxic substance whose risk of causing serious or catastrophic injury is greater than the benefit. If the risk exceeds the benefit then all reasonable practitioners would elect to choose to  instead use a safe and effective alternative therapy. How  can you ethically justify providing your society's imprimatur on a risky and dangerous technique when safe and time tested alternative therapies with proven effectiveness exist?  What is your rationale?

 

You say that the Sargenti method has successfully treated "many thousands of patients".  In reply I will quote from an FDA letter as they have replied to those same arguments in regard to Sargenti paste.

 

"The FDA does not "poll" users to determine drug effectiveness. "The responsibility for determining this rests with the drug manufacturer and must have some basis in science not testimonials," the letter stated, adding that adequate and well-controlled studies provide the basis for the agency's evaluation of a drug."


Also, your suggestion that patients have benefited from Sargenti is analogous to Merck arguing many patients benefited from Vioxx except those few who died or suffered debilitating strokes and heart attacks.  Because the risk exceeded the benefit and safe alternative drugs existed Merck withdrew Vioxx from the market anticipating the FDA would do likewise. The same FDA has specifically refused to approve Sargenti as safe and effective. Moreover, Sargenti proponents have had over three decades to prove its safety and effectiveness to the FDA and have yet to succeed. Does your society claim greater scientific expertise than the FDA?

 

Another analogy is to claim that speeding drivers get to their destinations faster and therefore speeding  is a more efficient way to travel. This argument ignores  those  speeding drivers who kill innocent people. The risk of serious injury or death is not worth the efficient way to speedily  travel and is therefore outlawed.  Even if most speeding drivers arrive safely and more quickly, it does not justify the risk of such an unsafe practice. How many more patients does Sargenti paste have to maim and destroy the quality of their life before your society will recognize the potential harm as your organization provides cover to Sargenti promoters with your implied recognition if not  endorsement? Is it one more, ten more or a hundred more maimed for life patients?  Most injured patients either don't discover that Sargenti paste injured them as the dentist frequently conceals what endodontic drug was used or even if told most patients accept their fate. Very few ever avail themselves of MedWatch reporting to the FDA. When is the last if not the first time you ever reported an adverse event to the FDA with a voluntary MedWatch report?  Are you any different in FDA MedWatch reporting than the vast majority of dentists?

 

Finally, as the director of Scientific Programs for the CDS which is allowing these Sargenti clinic tables, can you cite any research study that demonstrates comparative effectiveness and safety of Sargenti compared to conventional endodontic fillers and sealants? Ethical drug companies sell proven safe and effective endodontic fillers and sealants which U.S. dental schools teach as the recommended endodontic drug which should be used to fill and seal root canals? As an organization devoted to scientific progress and education I would hope you respond  by providing the scientific research that supports your tacit endorsement of an endodontic drug which mummifies nerve tissue. As Stephen Cohen, DDS, editor of Pathways of the Pulp, teaches in advocating against Sargenti, "No one should be embalmed before their time". Placing such a toxic drug in the hands of dentists who know that overfills on occasion happen is not worth the risk of mummifying the inferior alveolar and/or maxillary nerves, and damaging tissue, bone and blood vessels of patients such as myself and others.

 

Consequently, we the patient, pay the ultimate price for this unnecessarily toxic chemical. Is speedier endodontics with unsafe Sargenti worth this price? Primum non nocere teaches ethical dentists otherwise.

 

Yours for better dentistry through safer chemistry,

 

Claudia Megaro

 

 

 

Attachment:  Letter from CDS/Aloysius Kleszynski  to Claudia Megaro

 

 

 

cc: Daniel Bluthardt, Director ยท Division of Professional Regulation

     Michael McRaith, Acting Secretary of IDFPR

     Lisa Madigan, Attorney General

     Pat Quinn,  Lt Governor 

     Robert M. Wesley

     Barbara L. Mousel, DDS

     Anthony M. Spina, DDS, MD

     J. Michael Krisko, DDS

     Carlene R. Snell, RDH

     Alan J. Shapiro, DDS

     Randall B. Grove, Executive Director CDS

     Lennoree Cleary, Office Manager

     David Kumamoto, DDS

     Thomas E. Sullivan, DDS

     Ron Tankersley, DDS

     John S. Findley, DDS 

     J. Thomas Soliday, DDS

     W. Ken Rich, DMD

     Charles L. Steffel, DDS

     Edward J. Vigna, DDS

     Charles H. Norman, DDS 

     Samuel B. Low, DDS

     AAE

     CDS

     IDFPR

     ISDS

     ADA